EDITION JUNE 2019 ISSN 2521-7852 EULAR DO …...EDITION JUNE 2019 EULAR DO NOT MISS ISSN 2521-7852...

EDITION JUNE 2019

EULAR DO NOT MISS

ISSN 2521-7852

EULAR 2019 @ MADRID➢Oral presentations and posters

➢ “The young rheumatologist” sessions

➢Activities and get together

➢Mentor/Mentee meetings

➢EULAR-EMEUNET Ambassador Programme

➢Country Liaison Meeting

➢Educational Events

DIRECTORYDear young rheumatologistsand researchers,

We are delighted to present to you with a

new issue of EMEUNEWS, focusing on a

selection of Do Not Miss abstracts,

sessions and events at EULAR 2019.

The EULAR Congress is the largest

scientific event in rheumatology. To help

you get the most out of it, we provide a

selection of interesting oral presentations

and posters chosen by EMEUNET

Working Group members. We also

include selections from health

professionals in rheumatology and PARE

members. Although the abstracts

represent a personal and inevitably

limited selection from the vast amount

information to be presented, we believe

that our selections will provide some

inspiration to attendees.

This newsletter also contains details

about exciting networking events and

opportunities organized by EMEUNET

during the Congress. As EMEUNET is

celebrating its 10-year anniversary this

year, a special ‘anniversary dinner’ will

take place during the Congress.

EMEUNET will hold its usual booth within

the EULAR Village. Come to meet us

and get more information for our network

and activities. In addition to our physical

presence, EMEUNET will also be active

on social media including Facebook and

Twitter during the Congress. Check out

our pages for more information!

If this is your first contact with

EMEUNET, we invite you to explore

more and join us. If you are already part

of our community, we kindly remind you

that “sharing is caring”. Spread the word

about our activities and work, and help us

reach more young colleagues.

We hope you enjoy reading this

newsletter. We welcome all feedback,

comments, suggestions, and

contributions.

We wish you a prolific and successful

EULAR 2019. See you in Madrid!

Casper Webers and Antonis Fanouriakis,

on behalf of the Newsletter Subgroup

EULAR 2019: ORAL PRESENTATIONS & POSTERS 3

Basic Research I

Basic Research II

RA I

RA II

RA III

Psoriatic Arthritis

Axial Spondyloarthritis

SLE and APS

Other connective tissue diseases

Imaging

Osteoarthritis & Osteoporosis

Crystal Arthropathies

Rare and Autoinflammatory Diseases

Pediatric Rheumatology

Health Professionals in Rheumatology Sessions

PARE Sessions

THE YOUNG RHEUMATOLOGIST SESSIONS 19

EMEUNET EVENTS AT EULAR 2019 21

MENTOR MENTEE MEETINGS 23

EULAR EMEUNET AMBASSADOR PROGRAMME 25

COUNTRY LIAISONS MEETING 26

EDUCATIONAL EVENTS 27

JUNE 19

3

BASIC RESEARCH I

Type, n° Date, time Session Room Author Title

Oral

OP0076

Wednesday

12.06.2019

17:10

Cartilage,

Synovium and

Bone

N111/N112Hueber, A

(Germany)

JAK-INHIBITORS TOFACITINIB AND

BARICITINIB IMPROVE PATHOLOGICAL

BONE LOSS IN VIVO

Oral

OP0077

Wednesday

12.06.2019

17:20

Cartilage,

Synovium and

Bone

N111/N112Koenders, M

(Netherlands)

INNOVATIVE TRANSLATIONAL MODELS

TO STUDY HUMAN SYNOVIAL

PATHOLOGY: TARGET VALIDATION

AND PRECLINICAL IMAGING

Oral

OP0194

Thursday

13.06.2019

11:10

Genetics,

Epigenetics and

Immunity

N109/N110Bonelli, M

(Austria)

HISTONE DEACETYLASE 1 (HDAC1): A

KEY MEDIATOR OF T CELLS FOR THE

PATHOGENESIS OF RHEUMATOID

ARTHRITIS

Oral

OP0220

Thursday

13.06.2019

18:35

Fighting and

fixing: from

initiation to

resolution of

iinflammation

South

Auditorium

MacDonald, L

(United Kingdom)

SINGLE-CELL TRANSCRIPTOMIC AND

FUNCTIONAL ANALYSES REVEAL

NOVEL HETEROGENEITY IN

PATHOGENIC PATHWAYS MEDIATED

BY HUMAN SYNOVIAL TISSUE

MACROPHAGES,

Oral

OP0276

Friday

14.06.2019

10:30

SLE, Sjogrens’s

and APS –

etiology,

pathogenesis and

animal models

N111/N112Lucchesi, D

(United Kingdom)

DENDRITIC CELL-DERIVED IL-27

REGULATES THE MAGNITUDE OF

INDUCIBLE ECTOPIC GERMINAL

CENTRES BUT FAILS TO

DOWNMODULATE IL-17 PRODUCTION

IN CD4 T CELLS FROM PATIENTS WITH

SJÖGREN’S SYNDROME

Oral

OP0294

Friday

14.06.2019

11:00

Rheumatoid

Arthritis –

etiology,

pathogenesis and

animal models

N117/N118Perlman, H

(United States)

TRANSCRIPTIONAL PROFILING OF RA

PATIENTS SYNOVIAL TISSUE REVEALS

TARGETS FOR PRECISION MEDICINE

Poster

THU0006

Thursday

13.06.2019

11:45

Poster Tour T01

Cytokines and

inflammatory

mediators

Poster

Area

Zupanic, A

(Switzerland)

PROINFLAMMATORY RESPONSES IN

THE JAK-STAT PATHWAY IN SYNOVIAL

FIBROBLASTS ARE STIMULUS-

SPECIFIC AND ONLY PARTIALLY

INHIBITED BY THERAPEUTIC DOSES

OF TOFACITINIB

Poster

FRI0355

Friday

14.06.2019

11:45

Poster Tour F06

Spondlyloarthritis

– etiology,

pathogenesis and

animal models

Poster

Area

Cuthbert, R

(United Kingdom)

MUCOSAL ASSOCIATED INVARIANT T-

CELLS ARE ENRICHED AT THE HUMAN

ENTHESIS AND HAVE A RESIDENT

MEMORY PHENOTYPE

Sarah is an Arthritis Ireland Post-Doctoral Fellow at Trinity College Dublin, Ireland. Her main research interests include

synovial inflammation, dysregulated angiogenesis, inflammatory micro-environments and energy metabolism. Sarah is

a member of the Newsletter and Social Media Subgroups.

Genetics, cartilage/synovium, osteoimmunology, animal models

Sarah Wade

JUNE 19

ORAL PRESENTATIONS & POSTERS EULAR 2019 MADRID

4



Oral

SP0011

Wednesday

12.06.2109

14:20

Environmental

influences on

disease

development

South

Auditorium

Zaiss, M

(Germany)

HOW THE GUT INFLUENCES THE

IMMUNE SYSTEM

Oral

OP0141

Thursday

13.06.2019

10:30

VasculitisSouth

Auditorium

Watanabe, R

(United States)

CD28 AS A POTENTIAL THERAPEUTIC

TARGET FOR GIANT CELL ARTERITIS

Oral

OP0191

Thursday

13.06.2019

10:40

Genetics,

epigenetics and

immunity

N109/N110 Ge, X

(United Kingdom)

EPIGENETIC PROFILING OF SYNOVIAL

FIBROBLASTS REVEALS STRUCTURAL

DNA DYNAMICS AT DISEASE

IMPLICATED CHROMOSOME REGIONS

Oral

SP0104

Thursday

13.06.2019

17:55

Fighting and

fixing: from

initiation to

resolution of

inflammation

South

Auditorium

Hoffmann, M

(Germany)

THE JANUS-FACED GLADIATOR:

NEUTROPHILS IN STERILE

INFLAMMATION AND AUTOIMMUNITY

Oral

OP0290

Friday

14.06.2019

10:20

Rheumatoid

arthritis - etiology,

pathogenesis and

animal models

N117/N118 Elhai, M

(Switzerland)

HOTAIR IS INVOLVED IN JOINT

PATTERNING BY REGULATING FGFR2,

BMP2 AND WNT PATHWAYS

Oral

OP0277

Friday

14.06.2019

10:40

LE, Sjögren’s and

APS - etiology,

pathogenesis and

animal models

N111/N112 Filia, A

(Greece)

RNA SEQUENCING AND MACHINE

LEARNING TECHNIQUES PREDICT

MAJOR ORGAN INVOLVEMENT IN

PATIENTS WITH SYSTEMIC LUPUS

ERYTHEMATOSUS

Poster

SAT0005

Saturday

15.06.2019

10:30

Poster Tour S01:

Adaptive

immunity in

rheumatic

diseases

Poster areaLamacchia, C

(Switzerland)

DETECTION OF HIGHLY EXPANDED T

CELL CLONES IN THE PERIPHERAL

BLOOD OF AT RISK INDIVIDUALS FOR

RHEUMATOID ARTHRITIS BEFORE THE

CLINICAL ONSET OF THE DISEASE

Polona is researcher at the University Medical Centre Ljubljana, Slovenia. She completed her PhD studying

antiphospholipid syndrome. Her research interests include epidemiologic and diagnostic studies of systemic

autoimmune diseases, mostly SLE, APS and vasculitis. She is a member of the Social Media Subgroup.

BASIC RESEARCH II

Immunity, immunology

Polona Žigon

JUNE 19

5


Oral

SP0053

Thursday

13.06.2019

14.15

Clinical Science -

My Joints Hurt

And I’m

Overwhelmingly

Tired - Fatigue In

Rheumatoid

Arthritis

N103/N104Galloway, J

(United Kingdom)

HOW TO PREVENT AND MANAGE

FATIGUE IN PATIENTS WITH RA

Oral

OP0263

Friday

14.06.2019

10:40

Epidemiology N101/N102

Izadi, Z

(United States of

America)

HYDROXYCHLOROQUINE DOSING IN

PATIENTS WITH RHEUMATIC DISEASE

ACROSS THE U.S.: DATA FROM THE

RHEUMATOLOGY INFORMATICS

SYSTEM FOR EFFECTIVENESS (RISE)

REGISTRY

Oral

OP0265

Friday

14.06.2019

11:00

Epidemiology N101/N102Cook, M

(United Kingdom)

FRAILTY, DISABILITY, AND WORK

DISABILITY IN PEOPLE WITH

OSTEOARTHRITIS AND RHEUMATOID

ARTHRITIS

Poster

FRI0130

Friday

14.06.2019

11:45

Poster Tour F02

Rheumatoid

Arthritis - non

biologic treatment

Poster

Area

Rathbun, A

(United States of

America)

RELATIONSHIP BETWEEN

DEPRESSION AND DISEASE ACTIVITY

IN US VETERANS WITH EARLY

RHEUMATOID ARTHRITIS RECEIVING

METHOTREXATE

Oral

SP0162

Friday

14.06.2019

15:35

EULAR Projects

in Epidemiology

and Health

Services

Remission - The

Holy Grail?

Looking Across

Diseases

N117/N118Aletaha, D

(Austria)

REMISSION IN RA: DOES THE

DEFINITION MATTER?

Poster

SAT0557

Saturday

15.06.2019

10:30

Poster Tour S11

Public health,

health services

research, and

health economics

Poster

Area

Rodriguez, L

(Spain)

OUTPATIENT READMISSION IN

RHEUMATOLOGY: A MACHINE

LEARNING PREDICTIVE MODEL OF

PATIENT’S RETURN TO THE CLINIC

Polina is a post-doctoral researcher at Maastricht University (the Netherlands) and Monash University (Australia). Her

research interests are epidemiology of rheumatic diseases, health services research, socio-economic inequalities in

disease outcomes and patient health literacy. Polina is a member of the Peer Mentoring subgroup.

Epidemiology, clinical and non-biologics

Polina Putrik

RA I

Epidemiology, clinical and non-biologics

Polina Putrik

JUNE 19


6


Oral

OP0230

Friday

14.06.2019

11:30

Rheumatoid

arthritis -

biological

DMARDs

Hall 8Adami G

(Italy)

EFFECTIVENESS OF INFLUENZA

VACCINE IN TNF INHIBITORS TREATED

PATIENTS

Oral

LB0008

Sarurday

15.06.2019

08:30

Late breaking

abstractsHall 7B

Bykerk V

(United States)

THE EFFECT OF HLA-DRB1 RISK

ALLELES ON THE CLINICAL EFFICACY

OF ABATACEPT AND ADALIMUMAB IN

SEROPOSITIVE BIOLOGIC-NAÏVE

PATIENTS WITH EARLY, MODERATE-

TO-SEVERE RA: DATA FROM A HEAD-

TO-HEAD SINGLE-BLINDED TRIAL

Poster

SAT0120

Saturday

15.06.2019

10:30

Poster Tour S02

Rheumatoid

arthritis -

biological

DMARDs

Poster

Area

Chouqette, D

(Canada)

COMPARATIVE EFFECTIVENESS OF

TOFACITINIB AND TNF INHIBITORS

SINCE 2014. IMPACT OF

COMBINATION WITH METHOTREXATE

Poster

SAT0128

Saturday

15.06.2019

10:30

Poster Tour S02

Rheumatoid

arthritis -

biological

DMARDs

Poster

Area

Emery P

(United Kingdom)

A PHASE 4 TRIAL ASSESSING THE

IMPACT OF RESIDUAL INFLAMMATION

AND CLINICAL CHARACTERISTICS ON

THE OUTCOME OF DOSE TAPERING

OF ADALIMUMAB IN PATIENTS WITH

RHEUMATOID ARTHRITIS WHO ARE IN

STABLE CLINICAL REMISSION

Poster

SAT0595

Saturday

15.06.2019

10:30

Poster Tour S12

Epidemiology

and risk factors -

drug safety and

registries

Poster

Area

Grøn K

(Denmark)

DIRECT COMPARISON OF

CERTOLIZUMAB PEGOL, ABATACEPT

AND BIOSIMILAR INFLIXIMAB IN

PATIENTS WITH RHEUMATOID

ARTHRITIS TREATED IN ROUTINE

CARE. OBSERVATIONAL DATA FROM

THE DANISH DANBIO REGISTRY

ANALYZED LIKE A RANDOMIZED

CLINICAL TRIAL

Poster

SAT0127

Saturday

15.06.201

10:30

Poster Tour S02

Rheumatoid

arthritis -

biological

DMARDs

Poster

Area

Gerardi MC

(Italy)

LONG-TERM OUTCOME OF CHILDREN

BORN TO MOTHERS WITH CHRONIC

ARTHRITIS AND EXPOSED TO TNF-

INHIBITORS DURING PREGNANCY: A

CASE-CONTROL STUDY

Katja is postdoc in Immunology Laboratory, University Medical Centre Ljubljana, Slovenia and Assistant professor at

FAMNIT, University of Primorska. Her main research interests are acute phase response in rheumatic diseases and

fibrosis development in systemic sclerosis. She is member of the Education SG.

RA II

Biological therapies: Anti-TNFα

Katja Lakota

JUNE 19


7

RA III


Oral

OP0030

Wednesday

12.06.2019

17.25

RA therapy - JAK

inhibitors and

beyond

Hall 8Burmester, GR

(Germany)

RANDOMIZED CONTROLLED 24-WEEK

TRIAL EVALUATING THE SAFETY AND

EFFICACY OF BLINDED TAPERING

VERSUS CONTINUATION OF LONG-

TERM PREDNISONE (5 MG/D) IN


ARTHRITIS WHO ACHIEVED LOW

DISEASE ACTIVITY OR REMISSION ON

TOCILIZUMAB

Oral

OP0223

Friday

14.06.2019

10:20

Rheumatoid

arthritis - biological

DMARDs

Hall 8Tanaka, Y

(Japan)

EFFICACY AND SAFETY OF E6011, AN

ANTI-FRACTALKINE MONOCLONAL

ANTIBODY, IN MTX-IR PATIENTS WITH

RHEUMATOID ARTHRITIS

Oral

OP0228

Friday

14.06.2019

11:10

Rheumatoid


DMARDs

Hall 8Buckley, C

(United Kingdom)

GSK3196165 AN INVESTIGATIONAL ANTI-

GM-CSF MONOCLONAL ANTIBODY,

IMPROVES PATIENT REPORTED

OUTCOMES IN A PHASE IIB STUDY OF


ARTHRITIS (RA)

Poster

FRI0120

Friday

14.06.2019

11:45

Rheumatoid


DMARDs

Poster AreaStrand, V

(United States)

HIGH LEVELS OF INTERLEUKIN-6 (IL-6)

IN RA PATIENTS ARE ASSOCIATED WITH

GREATER IMPROVEMENTS IN PATIENT-

REPORTED OUTCOMES (PROS) FOR

SARILUMAB COMPARED WITH

ADALIMUMAB

Oral

LB0010

Saturday

15.06.2019

08:42

Late breaking

abstractsHall 7B

Verhoef, LM

(Netherlands)

ULTRA-LOW DOSES OF RITUXIMAB OR

RETREATMENT OF RHEUMATOID

ARTHRITIS: A RANDOMISED

CONTROLLED NON-INFERIORITY TRIAL

Poster

SAT0121

Saturday

15.06.2019

10:30

Poster Tour

S02: Rheumatoid


DMARDs

Poster AreaGenovese, MC

(United States)

EFFECT OF SARILUMAB ON

GLYCOSYLATED HEMOGLOBIN IN


ARTHRITIS AND DIABETES

Poster

SAT0124

Saturday

15.06.2019

10:30

Poster Tour

S02: Rheumatoid


DMARDs

Poster AreaPerez-Sanchez, C

(United Kingdom)

MOLECULAR CHARACTERIZATION OF

THE SERUM PROFILE ASSOCIATED TO

THE INCREASED CARDIOVASCULAR

RISK IN RHEUMATOID ARTHRITIS

PATIENTS. EFFECTS OF BIOLOGICAL

DRUGS.

Francesca is a rheumatologist working the Veneto Region, Italy. She works with the Rheumatology Unit of the the

University Hospital of Padova and with the Veneto Region Epidemiological Department. Her major research interests

include rheumatoid arthritis, biological drugs and patient reported outcomes. She is currently the leader of the Country

Liaisons Subgroup.

Biological therapies: Other biologics

Francesca Ometto

JUNE 19


PSORIATIC ARTHRITIS

8


Oral

OP0009

Wednesday

12.06.2019

14:15

Comorbidities in

Psoriatic ArthritisN103/N104

McInnes, I

(United Kingdom)

CARDIOVASCULAR RISK IN PSORIASIS

AND PSORIATIC ARTHRITIS

Oral

OP0007

Wednesday

12.06.2019

14:15

Comorbidities in

Psoriatic ArthritisN103/N104

Siebert, S

(United Kingdom)

HIGH BODY MASS INDEX (BMI) IN

PSORIATIC ARTHRITIS (PSA) IS

ASSOCIATED WITH HIGHER DISEASE

ACTIVITY IN JOINTS AND SKIN,

IMPAIRED QUALITY OF LIFE AND

MORE DISABILITY: RESULTS FROM

THE PSABIO STUDY

Oral

OP0108

Thursday

13.06.2019

10:15

Psoriatic arthritis:

old and new

drugs and how to

deal with them?

Hall 8Ritchlin, CT

(United States)

DUAL NEUTRALISATION OF IL-17A AND

IL-17F WITH BIMEKIZUMAB IN

PATIENTS WITH ACTIVE PSA: OVERALL

AND TNF-INHIBITOR-NAÏVE

POPULATION RESULTS FROM A 48-

WEEK PHASE 2B RANDOMISED STUDY

Oral

OP0109

Thursday

13.06.2019

10:15


old and new

drugs and how to

deal with them?

Hall 8Mease, PJ

(United States)

EFFICACY OF FILGOTINIB VS PLACEBO

IN ACTIVE PSORIATIC ARTHRITIS:

PATIENT-LEVEL DATA FROM

EQUATOR, A RANDOMIZED, PHASE 2

STUDY

Poster

FRI0357

Friday

14.06.2019

11:45

Unravelling the

pathogenesis of

spondyloarthritis:

a story of genes,

cells and

cytokines

Poster AreaAngioni, MM

(Italy)

DRUG-INDUCED REMISSION AND

SUBCLINICAL ACTIVITY IN PSORIATIC

ARTHRITIS: TRANSCRIPTIONAL

PROFILING TO CHARACTERIZE THE

DISEASE STATE

Poster

SAT0362

Saturday

15.06.2019

10:30

Poster Tour S06


old and new

drugs tackling the

different

manifestations of

psoriatic disease

Poster AreaNatalello, G

(Italy)

DEPRESSIVE SYMPTOMS ARE

ASSOCIATED WITH A GREATER

CARDIOVASCULAR RISK IN PATIENTS

WITH PSORIATIC ARTHRITIS

Poster

SAT0365

Saturday

15.06.2019

10:30

Poster Tour S06


old and new

drugs tackling the

different

manifestations of

psoriatic disease

Poster AreaHansen, RL

(Denmark)

SECULAR CHANGES IN PSORIATIC

ARTHRITIS PATIENTS STARTING FIRST

COURSE OF BIOLOGIC THERAPIES –

INFLAMMATORY HALLMARKS OF

LESSER PROMINENCE: A NORDIC

POPULATION-BASED COHORT STUDY

George is a rheumatology registrar at “Laiko” hospital, Athens, Greece. His main research interests include rheumatoid

and psoriatic arthritis and IgG4-related disease. He holds an honorary research fellow position at the University of

Glasgow, UK, carrying out research focused on inflammatory arthritis. George is member of the Newsletter Subgroup.

George Fragoulis

JUNE 19


9

AXIAL SPONDYLOARTHRITIS


Oral

Wednesday

12.06.2019

10:15

Best Practices in

Spondyloarthritis Hall 8

Machado, P

(United Kingdom)

A CRITICAL LOOK INTO TREAT-TO-

TARGET IN SPA

Oral

OP0033

Wednesday

12.06.2019

16:15

Abstract session:

Spondyloarthritis on

the move: Thrilling

developments

Hall 7ASepriano, A

(Netherlands)

WHAT IS AXIAL SPONDYLOARTHRITIS?

A LATENT CLASS AND TRANSITION

ANALYSIS IN THE SPACE AND DESIR

COHORTS

Oral

SP0080

Thursday

13.06.2019

15:30

From bench to

bedside:

Radiographic

progression in

arthritides: still valid

or a tale from the

past!?

Hall 7BPoddubnyy, D

(Germany)

STRUCTURAL DAMAGE PROGRESSION

IN AXSPA

Poster

THU0399

Thursday

13.06.2019

11:45

Spondyloarthritis -

clinical aspects

(other than

treatment)

Poster

Area

Proft, F

(Germany)

DEVELOPMENT OF AN OPTIMIZED

ONLINE SELF-REFERRAL TOOL FOR

EARLY RECOGNITION OF PATIENTS

WITH AXIAL SPONDYLOARTHRITIS

(AXSPA) – DATA FROM THE ’OPTIREF’-

STUDY

Poster

THU0363

Thursday

13.06.2019

11:45

Spondyloarthritis -

clinical aspects

(other than

treatment)

Poster

Area

Van Lunteren, M

(Netherlands)

DO ILLNESS PERCEPTIONS AND

COPING CHANGE OVER TIME IN

PATIENTS RECENTLY DIAGNOSED

WITH AXIAL SPONDYLOARTHRITIS? A

2-YEAR FOLLOW-UP STUDY IN THE

SPACE COHORT

Poster

FRI0372

Friday

14.06.2019

11:45

Spondyloarthritis -

clinical aspects

(other than

treatment)

Poster

Area

Muilu, P

(Finland)

DMARD TREATMENT AND OPIOID USE

IN EARLY SPONDYLOARTHRITIS IN

FINLAND

Poster

SAT0313

Saturday

15.06.2019

10:30

Spondyloarthritis -

clinical aspects

(other than

treatment)

Poster

Area

De Craemer, AS

(Belgium)

ILEAL BUT NOT COLONIC

INFLAMMATION IS LINKED TO FATTY

LESIONS ON MRI OF THE SACROILIAC

JOINTS IN SPONDYLOARTHRITIS

PATIENTS

Marloes is a staff rheumatologist at the Maastricht University Medical Center, Maastricht, The Netherlands. She

completed her dissertation on early identification and referral of patients suspected of having axial spondyloarthritis in

2015. Her research focuses on spondyloarthritis, rheumatoid arthritis and outcomes research. She is currently the

leader of the EMEUNET Education Subgroup.

Marloes van Onna

JUNE 19


10


Oral

OP0124

Thursday

13.06.2019

10:20

SLE, Sjögren and

APS: systemic

autoimmunity in

the real life

Hall 7B

Riancho-

Zarrabeitia, L

(Spain)

DO ALL ANTIPHOSPHOLIPID

ANTIBODIES CONFER THE SAME RISK

FOR MAJOR ORGAN INVOLVEMENT IN

SLE PATIENTS?

Oral

OP0129

Thursday,

13.06.2019

11:10

SLE, Sjögren and

APS: systemic

autoimmunity in

the real life

Hall 7B

Pineton de

Chambrun, M

(France)

CAPS CRITERIA FAIL TO IDENTIFY

MOST SEVERE PATIENTS WITH

ANTIPHOSPHOLIPID SYNDROME

ADMITTED TO THE INTENSIVE CARE

UNIT WITH A NEW THROMBOTIC

MANIFESTATION

Oral

OP0042

Thursday

13.06.2019

16:50

SLE, Sjögren’s

and APS -

treatment

Hall 7BTeng,O

(Netherlands)

LONG-TERM EFFECTS OF

SYNERGETIC B CELL

IMMUNOMODULATION WITH

RITUXIMAB AND BELIMUMAB

COMBINATION TREATMENT IN

SEVERE, REFRACTORY SLE: TWO

YEAR RESULTS

Oral

OP0043

Thursday

13.06.2019

17:00

SLE, Sjögren’s

and APS -

treatment

Hall 7BMathian, A

(France)

WITHDRAWAL OF A LOW DOSE (5 MG)

OF CORTICOSTEROIDS IN SYSTEMIC

LUPUS IN REMISSION FOR MORE

THAN A YEAR IS AT RISK OF RELAPSE

- THE CORTICOLUP TRIAL

Poster

FRI0176

Friday

14.06.2019

11:45

SLE, Sjögren’s

and APS -

treatment

Poster

Area

Merrill, J

(United States)

PHASE 2, DOUBLE-BLIND,

RANDOMIZED, PLACEBO-

CONTROLLED STUDY OF A

REVERSIBLE B CELL INHIBITOR,

XMAB®5871, IN SYSTEMIC LUPUS

ERYTHEMATOSUS (SLE)

Poster

FRI0177

Friday

14.06.2019

11:45

SLE, Sjögren’s

and APS -

treatment

Poster

Area

Miyagawa, I

(Japan)

THE ADDITIVE EFFECTS OF

HYDROXYCHLOROQUINE TO

MAINTENANCE THERAPY WITH

STANDARD OF CARE IN PATIENTS

WITH SYSTEMIC LUPUS

ERYTHEMATOSUS

Poster

FRI0179

Friday

14.06.2019

11:45

SLE, Sjögren’s

and APS -

treatment

Poster

Area

Alase, A

(United Kingdom)

PREDICTION OF RESPONSE TO

RITUXIMAB IN SLE USING A VALIDATED

TWO-SCORE SYSTEM FOR

INTERFERON

SLE AND APS

Peter Korsten

JUNE 19

Peter is a Rheumatologist and Attending Physician at University Medical Center Göttingen, Germany. His main

research interest is clinical outcome research and translational research in connective tissue diseases with a main

focus on lung and kidney involvement. He is also interested in conducting clinical trials, especially in small populations

and rare diseases. He is a member of the Education subgroup.


11


Oral

OP0039

Wednesday

12.06.2019

16:20

SLE, Sjögren’s

and APS -

treatment

Hall 7BBaer, A

(United States)

EFFICACY AND SAFETY OF

ABATACEPT IN ACTIVE PRIMARY

SJÖGREN’S SYNDROME: RESULTS OF

A RANDOMISED PLACEBO-

CONTROLLED PHASE III TRIAL

Oral

OP0062

Wednesday

12.06.2019

16:20

Myositis and

SSc: Clinical

Highlights 2019

N101/N102Zhu, H

(China)

IDENTIFICATION OF SIX

DERMATOMYOSITIS SUBGROUPS

USING PRINCIPAL COMPONENT

ANALYSIS-BASED CLUSTER ANALYSIS

Oral

OP0017

Wednesday

12.06.2019

16:45

Opening Plenary

Abstract SessionHall 6

Distler, O

(Switzerland)

NINTEDANIB REDUCED DECLINE IN

FORCED VITAL CAPACITY ACROSS

SUBGROUPS OF PATIENTS WITH

SYSTEMIC SCLEROSIS-ASSOCIATED

INTERSTITIAL LUNG DISEASE: DATA

FROM THE SENSCIS TRIAL

Oral

OP0126

Thursday

13.06.2019

10:40

SLE, Sjögren and

APS: systemic

autoimmunity in

the real life

Hall 7BRetamozo, S

(Argentina)

LYMPHOMA ARISING AT THE TIME OF

DIAGNOSIS OF PRIMARY SJÖGREN

SYNDROME: A HIGHLY-ACTIVE

SYSTEMIC SUBSET OF THE DISEASE

Oral

OP0186

Thursday

13.06.2019

11:10

Systemic

sclerosis,

myositis and

related

syndromes -

etiology,

pathogenesis and

animal models

N107/N108Stellato, M

(Switzerland)

LIN-GP38+ STROMAL CELLS ARE KEY

EFFECTOR CELLS IN MYOCARDIAL

FIBROSIS AND DEFECTS OF THE

CONDUCTION SYSTEM

Oral

OP0146

Thursday

13.06.2019

11:20

VasculitisSouth

Auditorium

Hatemi, G

(Turkey)

EFFICACY OF APREMILAST FOR ORAL

ULCERS ASSOCIATED WITH ACTIVE

BEHÇET’S SYNDROME OVER 64

WEEKS: RESULTS FROM A PHASE III

STUDY

Oral

OP0279

Friday

14.06.2019

11:00

SLE, Sjögren’s

and APS -

etiology,

pathogenesis and

animal models

N111/N112Pontarini, E

(United Kingdom)

A UNIQUE IL-21 SIGNATURE

CHARACTERIZES LESIONAL AND

CIRCULATING T-FOLLICULAR HELPER

CELLS IN SJÖGREN’S SYNDROME

PATIENTS WITH ECTOPIC GERMINAL

CENTRES AND MALT LYMPHOMA

Yuz is a National Institute for Health Research (NIHR) Academic Clinical Lecturer within the Leeds Institute of

Rheumatic and Musculoskeletal Medicine, University of Leeds and Acting Up Consultant Rheumatologist. His major

research interests include B-cell therapies, SLE, primary Sjogren’s, clinical trials, and biomarkers. Yuz is a member of

the EMEUNET Newsletter Subgroup.

OTHER CONNECTIVE TISSUE DISEASES

Including systemic sclerosis, myositis, vasculitis

Md Yuzaiful Md Yusof

JUNE 19


12


Oral

SP0025

Wednesday

12.06.2019

14:30

Capillaroscopy I N109/N110Herrick, A

(United Kingdom)

RELIABILITY IN THE LAST 10 YEARS:

CAPILLAROSCOPIC

CHARACTERISTICS VERSUS

INSTRUMENTAL DETECTION

Oral

OP0038

Wednesday

12.06.2019

17:25

Spondyloarthritis

on the move:

Thrilling

developments

Hall 7ARenson, T

(Belgium)

HIGH PREVALENCE OF SACROILIAC

BONE MARROW EDEMA ON MRI IN

POSTPARTUM WOMEN: A

TEMPORARY PHENOMENON

Poster

THU0070

Thursday

13.06.2019

11:45

Rheumatoid

arthritis -

prognosis,

predictors and

outcome

Poster AreaDakkak, Y

(Netherlands)

WHAT IS THE ADDITIONAL VALUE OF

MRI OF THE FOOT TO THE HAND IN

UNDIFFERENTIATED ARTHRITIS TO

PREDICT RHEUMATOID ARTHRITIS

DEVELOPMENT?

Poster

THU0366

Thursday

13.06.2019

11:45

Spondyloarthritis

- clinical aspects

(other than

treatment)

Poster AreaProtopopov, M

(Germany)

MAGNETIC RESONANCE IMAGING IN

COMPARISON WITH CONVENTIONAL

RADIOGRAPHY FOR DETECTION OF

STRUCTURAL CHANGES TYPICAL FOR

SPA – DATA FROM THE ASSESSMENT

OF SPONDYLOARTHRITIS

INTERNATIONAL SOCIETY (ASAS)

COHORT

Oral

OP0198

Thursday

13.06.2019

14:45

Can imaging

improve outcome

in OA ?

Hall 8Kwoh, CK

(United States)

MRI-DETECTED STRUCTURAL

ABNORMALITIES AND DEVELOPMENT

OF INCIDENT RADIOGRAPHIC KNEE

OSTEOARTHRITIS OVER 10 YEARS OF

FOLLOW-UP,

Poster

SAT0532

Saturday

15.06.2019

10:30

Diagnostics and

imaging

procedures

Poster AreaCarron, P

(Belgium)

IMMUNOSCINTIGRAPHY OF

SACROILIAC JOINTS SHOWS VERY

GOOD AGREEMENT WITH

INFLAMMATION ON MRI IN AXIAL

SPONDYLOARTHRITIS PATIENTS

Poster

SAT0532

Saturday

15.06.2019

10:30

Diagnostics and

imaging

procedures

Poster AreaKleinrensink, NJ

(Netherlands)

MRI DETECTS SUBCLINICAL PLANTAR

FASCIA AND ACHILLES TENDON

ENTHESITIS IN PATIENTS WITH

PSORIATIC ARTHRITIS, PSORIASIS

AND ANKYLOSING SPONDYLITIS

Oral

OP0343

Saturday

15.06.2019

13:05

To image or not

to image in

spondyloarthritis?

Hall 7BMaksymowych W

(Canada)

LONGITUDINAL ASSESSMENT OF MRI

OF THE SACROILIAC JOINTS IN THE

ASAS CLASSIFICATION COHORT:

EVOLUTION OF DIAGNOSTIC

FEATURES AND PREDICTIVE UTILITY

FOR AXIAL SPONDYLOARTHRITIS:

Olga is working in Department of Internal Medicine and The Rheumatology Clinic as a clinician, teaching and research

assistant. In addition, she has completed doctoral studies at the Department of Immunology and Allergy at Medical

University of Lodz where she investigates infectivity among the elderly, multi-morbidity and mechanisms of the

immune system's aging.

IMAGING

Olga Brzezińska

JUNE 19


13

OSTEOARTHRITIS & OSTEOPOROSIS


Oral

OP0011

Wednesday

12.06.2019

15:30

Pharmaceutical

pipeline in OA

N101/

N102

Kristensen, LE

(Denmark)

EFFECT OF LIRAGLUTIDE ON BODY

WEIGHT AND PAIN IN THE TREATMENT

OF OVERWEIGHT AND KNEE

OSTEOARTHRITIS: A RANDOMISED,

DOUBLE-BLIND, PLACEBO-

CONTROLLED STUDY

Oral

OP0076

Wednesday

12.06.2019

17:10

Cartilage,

synovium and

bone

N111/

N112

Adam, S

(Germany)

JAK-INHIBITORS TOFACITINIB AND

BARICITINIB IMPROVE PATHOLOGICAL

BONE LOSS IN VIVO

Oral

OP0085

Wednesday

12.06.2019

17:10

OsteoporosisN1117

N118

Aubry-Rozier, B

(Switzerland)

CAN WE AVOID THE LOSS OF BONE

MINERAL DENSITY ONE YEAR AFTER

DENOSUMAB DISCONTINUATION? THE

REOLAUS BONE PROJECT

Oral

OP0175

Thursday

13.06.2019

10:40

Osteoarthritis:

research in

motion

N117/

N118

Roux, C

(France)

METHOTREXATE IN PATIENTS WITH

HAND OSTEOARTHRITIS REFRACTORY

TO ANALGESICS: A RANDOMISED,

DOUBLE-BLIND, PLACEBO,

CONTROLLED TRIAL

Oral

OP0180

Thursday

13.06.2019

11:30

Osteoarthritis:

research in

motion

N117/

N118

Kroon, F

(Netherlands)

LOW-DOSE PREDNISOLONE IN

PATIENTS WITH HAND

OSTEOARTHRITIS (HOPE): RESULTS

FROM A RANDOMISED DOUBLE-BLIND

PLACEBO-CONTROLLED TRIAL

Poster

FRI0472

Friday

14.06.2019

11:45

Poster Tour F08

Osteoporosis

Poster

Area

Hagiwara, T

(Japan)

COMPARISON OF THE THERAPEUTIC

EFFICACY OF DAILY VERSUS WEEKLY

DOSE OF TERIPARATIDE FOR

PREVENTING BONE FRACTURE IN

PATIENTS WITH OSTEOPOROSIS – A

SINGLE CENTRE, PROSPECTIVE

OPEN-LABEL STUDY

Poster

FRI0468

Friday

14.06.2019

11:45

Poster Tour F08

Osteoporosis

Poster

Area

Berardi, S

(Italy)

EFFECTS OF DIFFERENT VITAMIN D

SUPPLEMENTATION SCHEMES IN

POSTMENOPAUSAL WOMEN

Gonçalo is a fellow in the department of internal medicine and clinical immunology at Pitié-Salpêtrière University

Hospital, Paris, France. His research focuses on the safety of biologics in rheumatoid arthritis and the pathophysiology

of systemic sclerosis with a specific interest in experimental inflammation driven fibrosis. Gonçalo is a member of the

Newsletter Subgroup.

Gonçalo Boleto

JUNE 19


14


Oral

OP0004

Wednesday

12.06.2019

15:30

Session: CPPD –

a forgotten

disease that

requires more

attention??!!!!

Hall 7BPascart, T

(France)

IS DUAL-ENERGY COMPUTED

TOMOGRAPHY ABLE TO IDENTIFY

EARLY-STAGE CALCIUM CRYSTAL

DEPOSITION IN VIVO? INITIAL

CLINICAL EXPERIENCE IN 132

PATIENTS WITH AND WITHOUT KNEE

CHONDROCALCINOSIS

Oral

OP0049

Wednesday

12.06.2019

16:40

Crystals N103/N104Richette, P

(France)

FACTORS ASSOCIATED WITH EARLY

FLARES WHEN INITIATING URATE

LOWERING THERAPIES. POST HOC

ANALYSIS OF CLEAR 1,2 AND

CRYSTAL TRIALS

Oral

OP0052

Wednesday

12.06.2019

17:10

Crystals N103/N104Lipsky, P

(United States)

DEVELOPMENT OF A MULTIVARIABLE

IMPROVEMENT MEASURE FOR GOUT

Oral

OP0207

Thursday

13.06.2019

14:35

Session: Getting

a grip on the

comorbidities in

gout

N111/N112Terkeltaub, R

(United States)

URATE-LOWERING THERAPY WITH

VERINURAD AND FEBUXOSTAT

REDUCES SERUM URIC ACID AND

ALBUMINURIA IN HYPERURICEMIC

PATIENTS WITH DIABETES

Poster

SAT0413

Saturday

15.06.2019

10:30

Poster SessionPoster

Area

Bayat, S

(Germany)

SIZE MATTERS – EXTENT OF

MONOSODIUM URATE DEPOSITS BUT

NOT SERUM URATE LEVEL PREDICTS

COMPLETE RESOLUTION OF

MONOSODIUM URARE CRYSTAL

DEPOSITS IN PATIENTS WITH GOUT

Poster

SAT0403

Saturday

15.06.2019

10:30

Poster Tour S07

Crystals

Poster

Area

Wanten, S

(Netherlands)

SEX DIFFERENCES ARE PRESENT IN

CLINICAL CHARACTERISTICS, BUT

NOT IN RESPONSE TO DIFFERENT

URATE LOWERING THERAPIES IN

PATIENTS WITH GOUT

Poster

SAT0404

Saturday

15.06.2019

10:30

Poster Tour S07

Crystals

Poster

Area

Botson, J

(United States)

PRETREATMENT AND CO-

ADMINISTRATION WITH

METHOTREXATE IMPROVED

DURABILITY OF PEGLOTICASE

RESPONSE: A PROSPECTIVE,

OBSERVATIONAL, PROOF-OF-

CONCEPT, CASE SERIES

Poster

SAT0410

Saturday

15.06.2019

10:30

Poster Tour S07

Crystals

Poster

Area

Bardin, T

(France)

RADIOGRAPHIC EROSION SCORE

IMPROVED WITH TARGETED URATE-

LOWERING THERAPY IN A

PROSPECTIVE GOUT VIETNAMESE

COHORT

Mary Lucy is a rheumatology fellow at Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal and a PhD

applicant at the Rheumatology Department, Leiden University Medical Center, The Netherlands. Her main research

interests include spondyloarthritis, osteoporosis, imaging, and outcomes research. Mary is a member of the Country

Liaison Subgroup and a liaison to the Social Media Subgroup.

METABOLIC AND CRYSTAL

ARTHROPATHIES

Mary Lucy Marques

JUNE 19


15

RARE AND AUTOINFLAMMATORY

DISEASES

Simon Stones is a patient advocate and consultant. He is currently completing is PhD in Applied Health

Research/Paediatric Rheumatology at University of Leeds, UK. Simon focuses on supported self-management of

paediatric rheumatological conditions. He is a member of the EMEUNET Social Media subgroup, and former founding

member of Young PARE.


Poster

THU0555

Thursday

13.06.2019

11:45

Poster Tour T10

Other orphan

diseases - Know rare

diseases much better

Poster AreaEgeli, BH

(Turkey)

10 YEAR PROGNOSIS OF

PATIENTS DIAGNOSED WITH

FAMILIAL MEDITERRANEAN

FEVER

Poster

THU0564

Thursday

13.06.2019

11:45

Poster Tour T10

Other orphan

diseases - Know rare

diseases much better

Poster AreaRonicke, S

(Germany)

COULD A PROBABILISTIC

REASONING AI ACCELERATE

RARE DISEASE DIAGNOSIS?

EVALUATING THE POTENTIAL

IMPACT OF A DIAGNOSTIC

DECISION SUPPORT SYSTEM IN

A RETROSPECTIVE STUDY

Oral

Thursday

13.06.2019

15:55

Difficult to manage

Sjogren's syndrome

and myositis

N103/N104Gerli, R

(Italy)

SJOGREN’S SYNDROME WITH

NEUROLOGICAL INVOLVEMENT

Oral

OP0255

Friday

14.06.2019

10:30

Tackling the

challenges of

autoimmune /

autoinflammatory

conditions in children

and young people

South

Auditorium

Bracaglia, C

(Italy)

MICROBIOTA TRANSPLANT TO

CONTROL INFLAMMATION IN A

NLRC4-RELATED DISEASE

PATIENT WITH RECURRENT

HEMOPHAGOCYTIC

LYMPHOHISTIOCYTOSIS (HLH)

Oral

OP0244

Friday

14.06.2019

11:10

SSc and myositis –

Novel therapeutic

options

Hall 7BZhang, S

(China)

EFFICACY AND SAFETY OF

LOW-DOSE IL-2 IN PATIENTS

WITH MULTIPLE

MYOSITIS/DERMATOMYOSITIS

Oral

SP0125

Friday

14.06.2019

13:55

New assessments in

clinical practiceN111/N112

Luqmani, R

(United Kingdom)

HOW TO ASSESS PATIENT WITH

SUSPECTED VASCULITIS

Poster

SAT0682

Saturday

15.06.2019

10:30

Poster Tour S14

How to improve your

education

Poster AreaFarhat, M

(France)

PATIENT EDUCATION IN THE

EUROPEAN REFERENCE

NETWORK ON RARE AND

COMPLEX CONNECTIVE TISSUE

AND MUSCULOSKELETAL

DISEASES (ERN RECONNET):

UNMET NEEDS FROM THE

HEALTH CARE PROVIDERS SIDE

AND FROM THE PATIENTS’ SIDE.

Simon Stones


JUNE 19

16


Oral

SP0020

Wednesday

12.06.2019

14:40

EULAR Projects in

Paediatric

Rheumatology

N117/

N118

Scott, C

(South

Africa)

THE GLOBAL CHALLENGE AND

OPPORTUNITY FOR PAEDIATRIC

RHEUMATOLOGY

Oral

OP0059

Wednesday

12.06.2019

17:05

JIA: From new

horizons of treatment

to perspectives of

current ones

South

Auditorium

Uva, A

(Italy)

PERIARTICULAR GLUCOCORTICOID

INJECTIONS: DELINEATING THEIR USE

IN JUVENILE IDIOPATHIC ARTHRITIS

Oral

OP0151

Thursday

13.06.2019

10:50

Journeys from bench

to bedside in

paediatric

rheumatology

N101/

N102

Tenbrock, K

(Germany)

MIRNAS CONTRIBUTE TO

DYSREGULATED ROS METABOLISM OF

IMMUNE CELLS IN THE INFLAMED JOINT

Poster

THU0655

Thursday

13.06.2019

11:45

Poster Tour T09

How can we improve

our care of children

and young people

with paediatric

rheumatic disorders?

Poster

Area

Giancane, G

(Italy)

LONG-TERM OUTCOME OF JUVENILE

IDIOPATHIC ARTHRITIS: COMPARISON

OF BIOLOGIC AND METHOTREXATE

ERAS

Oral

OP0204

Thursday

13.06.2019

14:35

Adults are just grown

up children! Discuss

N101/

N102

De

Benedetti, F

(Italy)

EMAPALUMAB, AN INTERFERON GAMMA

(IFN-Y)-BLOCKING MONOCLONAL

ANTIBODY, IN PATIENTS WITH

MACROPHAGE ACTIVATION SYNDROME

(MAS) COMPLICATING SYSTEMIC

JUVENILE IDIOPATHIC ARTHRITIS (SJIA)

Oral

OP0205

Thursday

13.06.2019

14:45

Adults are just grown

up children! Discuss

N101/

N102

Moshe

Bergonzo, V

(Israel)

LIVE ATTENUATED VACCINES IN

PEDIATRIC RHEUMATIC DISEASES ARE

SAFE: MULTICENTER, RETROSPECTIVE

DATA COLLECTION

Oral

OP0255

Friday

14.06.2019

10:30

Tackling the

challenges of

autoimmune /

autoinflammatory

conditions in children

and young people

South

Auditorium

Bracaglia,C

(Italy)

MICROBIOTA TRANSPLANT TO

CONTROL INFLAMMATION IN A NLRC4-

RELATED DISEASE PATIENT WITH

RECURRENT HEMOPHAGOCYTIC

LYMPHOHISTIOCYTOSIS (HLH)

Oral

OP0342

Saturday

15.06.2019

10:20

Tackling inflammatory

bone disorders in

children and adults

N117/

N118

Oliver, M

(United

States)

IDENTIFYING CANDIDATE ITEMS

TOWARDS THE DEVELOPMENT OF

CLASSIFICATION CRITERIA FOR

CHRONIC NONBACTERIAL

OSTEOMYELITIS (CNO) AND CHRONIC

RECURRENT MULTIFOCAL

OSTEOMYELITIS (CRMO)

Lovro is a pediatric rheumatologist and academic researcher from Zagreb, Croatia, currently doing a postdoctoral

fellowship at University of British Columbia and BC Children’s Hospital in Vancouver, Canada. His research interests

are mainly focused on juvenile spondyloarthritis and autoinflammatory diseases. He is a head of Emerging Pediatric

Rheumatologist and Researchers (PReS EMERGE), a group closely working with EMEUNET on a number of initiatives.

PEDIATRIC RHEUMATOLOGY

Lovro Lamot

JUNE 19


17



Oral

OP0079-

HPR

Wednesday

12.06.2019

17:20

Rehabilitation;

opening Pandora’s

Box

N115/

N116

Stocker, J

(Netherlands)

NON-PHARMACOLOGICAL CARE IN

SYSTEMIC SCLEROSIS:OPENING THE

BLAX BOX

Poster

THU0716-

HPR

Thursday,

13.06.2019

11:45

HPR Patients’

perspectives,

functioning and

health

Poster

Area

Davergne, T

(France)

MAJOR BARRIERS AND FACILITATORS

TO PHYSICAL ACTIVITY IN

RHEUMATOID ARTHRITIS ARE

RELATED TO PHYSICAL AND

PSYCHOLOGICAL HEALTH, SETTING

AND SOCIAL ENVIRONMENTAL

FACTORS: A SYSTEMATIC

LITERATURE REVIEW

Poster

THU0697-

HPR

Thursday,

13.06.2019

11:45

HPR Service

developments,

innovation and

economics

Poster

Area

Elmacioglu, M

(Netherlands)

CONTENT OF AND

RHEUMATOLOGISTS’ AND NURSES’

OPINIONS ON A NURSE-LED

TELEPHONE HELPLINE

Oral

OP0217-

HPR

Thursday,

13.06.2019

16:47

How not to smoke

like a chimney

N105/

N106

Roelsgaard, IK

(Denmark)

EVALUATION OF PATIENTS’

EXPERIENCES OF AN INTENSIVE

SMOKING CESSATION INTERVENTION

FOR PEOPLE WITH RHEUMATOID

ARTHRITIS

Poster

FRI0710-

HPR

Friday,

14.06.2019

11:45

HPR Patients’

perspectives,

functioning and

health

Poster

Area

Estevez-Lopez, F

(Spain)

EFFECTIVENESS OF EXERCISE IN THE

MANAGEMENT OF FATIGUE AND

SLEEP QUALITY IN FIBROMYALGIA: A

SYSTEMATIC REVIEW AND META-

ANALYSIS

Poster

FRI0720-

HPR

Friday,

14.06.2019

11:45

HPR Patients’

perspectives,

functioning and

health

Poster

Area

Malory, R

(France)

DEVELOPMENT AND VALIDATION OF A

SELFADMINISTRATED

QUESTIONNAIRE MEASURING

ESSENTIAL KNOWLEDGE FOR


ARTHRITIS: THE RHEUMATOID

ARTHRITIS ASSESSMENT

KNOWLEDGE QUESTIONNAIRE (RAKE)

Poster

FRI0721-

HPR

Friday,

14.06.2019

11:45

HPR Patients’

perspectives,

functioning and

health

Poster

Area

Santos, E

(Portugal)

EFFECTIVENESS OF NON-

PHARMACOLOGICAL AND NON-

SURGICAL INTERVENTIONS ON THE

IMPACT OF RHEUMATOID ARTHRITIS:

AN OVERVIEW OF REVIEWS

Poster

SAT0726-

HPR

Saturday,

15.06.2019

10:30

HPR Service

developments,

innovation and

economics

Poster

Area

Diaz, SG

(Spain)

EHEALTH CONSULTATIONS IN

RHEUMATOLOGY MANAGED BY

NURSING. SPANISH NATIONAL

DESCRIPTIVE STUDY

Ricardo is a nurse at Centro Hospitalar e Universitário de Coimbra and researcher at The Health Sciences Research

Unit: Nursing, Coimbra, Portugal. His main research interests are patient reported outcomes and remission definition

in RA, patient education, effectiveness of nursing and other non-pharmacological interventions. He collaborates with

the EMEUNET initiatives on behalf of EULAR Health Professional in Rheumatology (HPR).

HEALTH PROFESSIONALS IN

RHEUMATOLOGY (HPR) SESSIONS

Ricardo Ferreira

JUNE 19

18

PEOPLE WITH ARTHRITIS/RHEUMATISM

IN EUROPE (PARE)

Simon Stones is a patient advocate and consultant. He is currently completing is PhD in Applied Health

Research/Paediatric Rheumatology at University of Leeds, UK. Simon focuses on supported self-management of

paediatric rheumatological conditions. He is a member of the EMEUNET Social Media subgroup, and former founding

member of Young PARE.


Oral

SP0028

Wednesday

12.06.2019

16:45

Bringing digital health

care solutions to

patients

N105/

N106

Najm, A

(France)

WHAT SHOULD MOBILE HEALTH

APPLICATIONS FOR RMD

PATIENTS BE LIKE?

Oral

SP0042

Thursday

13.06.2019

10:40

From child to adult

care - Breaking down

the barriers of

transition

N115/

N116

Ammerlaan, J

(Netherlands)

FROM PAEDIATRIC CARE TO

ADULT CARE – THE NEEDS OF

YOUNG PEOPLE, AND HOW

HEALTHCARE PROFESSIONALS

CAN FACILITATE OPTIMAL

TRANSITION

Oral

OP0209-

PARE

Thursday

13.06.2019

14:47

Treatment is more

than drugs

N115/

N116

Hongisto, T

(Finland)

IMPROVING MENTAL WELLBEING -

COACHING PEERS TO USE

TOOLKIT FOR MIND

Oral

OP0218-

PARE

Thursday

13.06.2019

16:35

Should we worry

about anything else –

Also young people

have multi-morbidities

N115/

N116

Gerhart, W

(Canada)

PREVENTATIVE MEDICINE

THROUGH IDENTIFYING AND

ADDRESSING COMORBIDITIES OF

SPONDYLOARTHRITIS (SPA*) TO

IMPROVE PATIENT OUTCOMES

THROUGH PATIENT

ORGANIZATION PARTNERSHIPS

AND ALLIED HEALTHCARE

OUTREACH

Oral

OP0287-

PARE

Friday

14.06.2019

11:05

PARE Abstract

Session I

N115/

N116

Grosjean, A

(Switzerland)

SETTING UP A EUROPEAN

FEDERATION OF SJÖGREN’S

SYNDROME PATIENT

ASSOCIATIONS: HOW WE BUILT UP

SJÖGREN EUROPE IN LESS THAN

ONE YEAR

Poster

PARE0015

Friday

14.06.2019

12:00

PARE Poster Tour II

PARE

Poster

Area

Bosworth, A

(United Kingdom)

EMOTIONAL HEALTH AND WELL-

BEING MATTERS

Oral

OP0321-

PARE

Friday

14.06.2019

14:30

The benefits of

involving patients in

health technology

assessment

N115/

N116

Silva, M

(Belgium)

A NOVEL APPROACH TO REACH

PATIENTS FOR EDUCATIONAL

PURPOSES - VIRTUAL

CONFERENCE REUMANET

Oral

SP0206

Saturday

15.06.2019

12:05

Restless lives:

Managing fatigue,

sleep and pain

N115/

N116

Lange, T

(Germany)

LINKS BETWEEN SLEEP QUALITY

AND IMMUNITY IN RMDS

Simon Stones


JUNE 19

19

Wednesday 12.06.2019

14:15 – 15:45

Friday 14.06.2019

15:30 – 17:00

THE YOUNG RHEUMATOLOGIST SESSIONS

How to perform low-budget high-quality research (N111/N112)

Chair: Prof. Dr. Loreto Carmona (Spain)

Chair: Dr. Sebastian Rodriguez-Garcia (Spain)

Speaker: Laure Gossec (France)

HOW TO ORGANIZE A VERY SMALL RESEARCH UNIT

Speaker: Loreto Carmona (Spain)

SP0016 YOUR VERY FIRST STEPS ON SYSTEMATIC REVIEW

Speaker: Daniel Prieto-Alhambra (United Kingdom)

SP0017 USING AVAILABLE DATASETS TO ANSWER NEW RESEARCH

QUESTIONS

Abstract: Mr. Andriko Palmowski (Germany)

OP0014 NO ASSOCIATION BETWEEN THE PROPORTION OF ELDERLY PEOPLE

AND TRIAL RETENTION IN RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS

TRIALS: A SYSTEMATIC REVIEW WITH META-REGRESSION ANALYSES

Abstract: Dimitrios Vassilopoulos (Greece)

OP0015 INCIDENCE, RISK FACTORS AND VALIDATION OF THE RABBIT SCORE

FOR SERIOUS INFECTIONS IN A REAL LIFE PROSPECTIVE STUDY OF

PATIENTS WITH RHEUMATOID ARTHRITIS: DATA FROM 1.549 PATIENTS

Missing data in clinical research: To impute or not to impute, that is the

question (N111/N112)

Chair: Prof. Dr. Loreto Carmona (Spain)

Chair: Dr. Alexandre Sepriano (Netherlands)

Speaker: Stian Lydersen (Norway)

SP0156 MISSING DATA: IS IT ALL THE SAME?


SP0157 PRO SESSION: IMPUTATION IS A POWERFUL ANALYTICAL TOOL,

WHEN APPROPRIATELY USED

Speaker: Maxime Dougados (France)

SP0158 CON SESSION: PREPARE YOUR DATA COLLECTION WELL:

IMPUTATION DOES NOT REPLACE ‘REAL DATA’


SUMMARY PROS AND CONS

ACTIVE AUDIENCE PARTICIPATION

JUNE 19

20

Saturday 15.06.2019

12:00-13:30

THE YOUNG RHEUMATOLOGIST SESSIONS

How to build a clinical scientist (N111/N112)

Chair: Marloes van Onna (Netherlands)

Chair: Victoria Navarro-Compán (Spain)

Speaker: Iain McInnes (United Kingdom)

DIFFICULTIES ARE PART OF BRILLIANT CAREERS

Speaker: Annet van Royen (Netherlands)

SP0205 SCIENCE CAREER AND MENTAL HEALTH

Speaker: Johannes Bijlsma (Netherlands)

ALTERNATIVE’ CAREER CHOICES CAN BE A REAL BONUS

ROUND TABLE DISCUSSION

JUNE 19

EMEUNET Networking Event at

#EULAR2019 M a d r i d

Sunshine and interesting results on rheumatic topics can go hand-in-

hand. This is shown at the annual meeting of the EULAR, which this

year is in Madrid. With all the scientific activities during the day

EMEUNET would like to invite you all to join us for some networking

time on Thursday evening June 14th.

This year is special for EMEUNET as we will celebrate our

10 year anniversary

Together with the support of EULAR we will give you a reception with

drinks, a 3-course dinner and transportation to and from the venue,

for €25 in total (20.00h @El Jardin de la Maquina).

Pick-up is arranged from several locations in the center of Madrid

and at the convention center. Details will be provided after

registration.

!!! There is a limited number of places available !!! Make sure you are

part of this experience and buy your ticket at:

https://emeunet.eventsmart.com/events/emeunet-10th-anniversary-

dinner-at-eular-2019-in-madrid/

We are looking forward to seeing you all in Madrid!

Your EMEUNET Visibility SubGroup

21JUNE 19

https://emeunet.eventsmart.com/events/emeunet-10th-anniversary-dinner-at-eular-2019-in-madrid/

22

Again at EULAR 2019 in Madrid, we welcome you all to our EMEUNET booth,

which will be open for everyone to visit during the conference.

We hope you will pass by our booth at the EULAR Village. We are happy to greet

you and will give you information about our activities.

Why not bring your colleagues along who may or may not (yet!) be EMEUNET

members? For those not yet part of our network, it will be possible to join

EMEUNET directly by registering at the booth!

New this year: at the EMEUNET booth there will be a quiz with questions on

EMEUNET and EULAR. Of course a quiz is nothing without prizes, so make sure

to test your knowledge!

Follow EMEUNET on Facebook and Twitter to get real-time updates!

EMEUNET BOOTH AT EULAR 2019

JUNE 19

For more information and how to join go to http://emeunet.eular.org/mentor_mentee.cfm and visit our

YouTube channel.

HOW TO APPLY? Just send an email with your name, photo (face snapshot), position and institution

as well as the mentoring group you would like to join to: [email protected]

23

THE MENTOR MENTEE MEETINGS AT EULAR 2019

As you all know, one of the missions of EMEUNET is to increase mentor-mentee interaction.

EMEUNET offers you a unique opportunity to discuss possible career options, research topics,

involvement in EULAR or professional skills with top leaders in the field of rheumatology in the

setting of the EULAR annual congress: the EMEUNET Mentor-Mentee meetings. This activity

takes place under a casual atmosphere and no materials are needed to be prepared in

advance. Previous mentor-mentees meetings at EULAR and ACR have been very interactive and

were scored as very satisfactory by mentees. Sign up for the mentor-mentee meetings at EULAR

2019! The next mentor-mentee will take place on Friday 14th of June at 08:00 – 9.30 am in

room S15 of the congress venue. The number of mentees will be limited to 6-8 for each group to

enhance interaction.

For the 10th anniversary of EMEUNET, we have prepared a fresh format of this activity, including

for the first time two mentors per discussion group. Do not miss this opportunity! The mentors

for this edition will be:

PROF. KIMME HYRICH

(The University of Manchester and Manchester University Hospitals NHS

Foundation Trust, Manchester, United Kingdom)

Keywords: Clinical epidemiology, outcomes research, inflammatory arthritis

DR. SOFIA RAMIRO

(Leiden University Medical Centre, Leiden, Netherlands)

Keywords: Clinical epidemiology, outcomes research, spondyloarthritis

GROUP 1: HYRICH & RAMIRO

JUNE 19

http://emeunet.eular.org/mentor_mentee.cfm

https://www.youtube.com/watch?v=d0Khc0HLeHQ

HOW TO APPLY? Just send an email with your name, photo (face snapshot), position and institution

as well as the mentoring group you would like to join to: [email protected]

YOUR OPINION IS IMPORTANT!

If you are one of the mentees that will participate to the meetings give us your feedback after the

event and it will be included in the next newsletter issue!

24

THE MENTOR MENTEE MEETINGS AT EULAR 2019

PROF. DENIS PODDUBNYY

(Charité Campus Benjamin Franklin, Berlin, Germany)

Keywords: Early diagnosis, treatment, imaging, outcomes research,

spondyloarthritis

GROUP 2: PODDUBNYY & NAVARRO-COMPÁN

DR. VICTORIA NAVARRO-COMPÁN

(University Hospital La Paz, IdiPaz, Madrid, Spain)

Keywords: Imaging, outcomes research, spondyloarthritis, rheumatoid

arthritis

GROUP 3: VENCOVSKY & VAN BAARSEN

PROF. JIRI VENCOVSKY

(Institute of Rheumatology, Prague, Czech Republic)

Keywords: Myositis, autoantibodies, treatment of rheumatoid arthritis

DR. LISA VAN BAARSEN

(Amsterdam UMC, University of Amsterdam, Netherlands)

Keywords: Genomics, immunology, translational research, cell biology,

stromal cells

JUNE 19

25

THE EULAR-EMEUNET AMBASSADOR PROGRAMME

FOR FIRST TIME ATTENDEES

Is it your first time to attend the EULAR annual conference this year? Attending the largest

european rheumatology congress for the first time can be a daunting experience. The annual

EULAR meeting welcomes 14,000+ clinicians and scientists, discussing clinical management, and

new scientific findings in an overwhelming number of sessions which run in parallel, starting early

in the morning and ending late at night. There has been a tradition that senior attendees share the

skills on how to survive the annual EULAR meeting, on how to get a taste of everything and not

miss the important facts, and have a great time. But how can you find your way through countless

opportunities within four days?

We invite 30 fellows who are first or second-time attendees to the conference to be part of our

EULAR/EMEUNET ambassador programme and receive congress mentorship from EULAR

veterans on how to make the most of your time.

• Applicants will be selected on a first-come, first-served basis

• Participants will be allocated to small groups, each with a EULAR ambassador from the

EMEUNET working group. [Don’t worry: EMEUNET ambassadors are still young (<40 years)

and very approachable]

• You will be invited to the welcome meeting on the first day of the congress, so that you can meet

other fellow first time attendees and your ambassadors in an informal setting

• Participants will learn how to master the clinical and scientific EULAR programme and will be

offered the chance to participate in the EMEUNET networking events

• The mentoring process will be very informal

• The programme is free for EMEUNET members and non-members

YOUR OPINION IS IMPORTANT

If you are one of the participants to the

programme give us your feedback after the

event and it will be included in the next

newsletter issue!

JUNE 19

26

COUNTRY LIAISONS MEETING AT EULAR 2019

The Country Liaisons are the representatives of EMEUNET in each country and are in charge of promoting

an active network of rheumatologists, fellows and researchers. Currently we work together with 45 Country

Liaisons in all Europe. Thanks to the continuous effort of the Country Liaisons, young rheumatologists,

researchers and fellows are invited to join EMEUNET. Through them, the educational and career

development opportunities offered by EMEUNET/EULAR find their way to young rheumatologists and

researchers. The Country Liaisons also play the key role of providing feedback from the community of

European young rheumatologists/fellows and researchers to EMEUNET/EULAR, to continuously adapt

educational offers and activities to the target population.

Since 2014, the members of the Country Liaison Subgroup and the Country Liaisons meet during a specific

event on a yearly basis, the EMEUNET Country Liaisons Meeting. The meeting is a wonderful

opportunity to introduce the new Country Liaisons and it also allows us to share experiences and discuss

about how to improve the local promotion of EMEUNET, increase our visibility, and improve communication

among all parties involved. Since its first edition, it has been a very productive and lively meeting!

The 6th Country Liaison Meeting is going to take place during the upcoming EULAR Congress in Madrid.

On Thursday, June 13th, 17.00-19.00, we once again invite all EMEUNET Country Liaisons to meet

together! We will review the highlights of the past year and invited Country Liaisons will share their

experiences in promoting EMEUNET in their countries.

We count on your participation and feedback for an exciting discussion!

EMEUNET Country Liaisons, book the date!Thursday, June 13th, 17.00-19.00, Room A10.01, EULAR Congress Venue

(IFEMA, Feria de Madrid)We hope to see you all in Madrid!

Your EMEUNET Country Liaison Subgroup

YOUR OPINION IS IMPORTANT!

If you are one of the Country

Liaisons that is participating at the

meeting give us your feedback

after the event and it will be

included in the next newsletter

issue!

Just send an email to any of the

Country Liaison Subgroup

members and we will do the rest! 5th Country Liaison Meeting at EULAR 2018

JUNE 19

27

JUNE 2019

EDUCATIONAL EVENTS

JUNE 2019

EULAR School of Rheumatology: 8th EULAR Course for Ultrasound Trainers in

Rheumatology

o When and Where: 8-9 June, Madrid, Spain

o Website: https://esor.eular.org/enrol/index.php?id=56

EULAR School of Rheumatology: 26th EULAR Ultrasound Courses, Basic,

Intermediate and Advanced


o Website: https://esor.eular.org/enrol/index.php?id=52

BIR Imaging in Rheumatology Study Day

o When and Where: 11 June, London, United Kingdom

o Website: https://www.bir.org.uk/

EULAR Congress 2019


o Website: http://www.congress.eular.org/

12th International Conference on Arthroplasty

o When and Where: 24-25 June, Rome, Italy

o Website: https://arthroplasty.cmesociety.com/

ESSR 2019 Musculoskeletal Radiology

o When and Where: 26-29 June, Lisbon, Portugal

o Website: https://www.essr.org/congress/essr-2019/

JUNE 19

https://esor.eular.org/enrol/index.php?id=56

https://esor.eular.org/enrol/index.php?id=52

https://www.bir.org.uk/

http://www.congress.eular.org/

https://arthroplasty.cmesociety.com/

https://www.essr.org/congress/essr-2019/

NEW: EMEUNET ON COURSE

28

NEW INITIATIVE: EMEUNET ON COURSE

EMEUNET is testing a new initiative for rheumatologists taking the EULAR online courses called

#EMEUNETonCourse. The purpose of the initiative is to create a platform for interaction while taking

one of the EULAR online courses. The idea is that this will make learning more effective for the course

attendants and at the same time get more rheumatology related content on #MedicalTwitter.

The initiative is grounded on Twitter. Anyone can Tweet anything with relevance to one of the EULAR

online courses they are taking. E.g. a summary to help others, special clinical pearls, controversies for

debate etc. The hashtags used are the same as the name of the course, e.g. hashtag for the EULAR

online course on rheumatic diseases (the 2-year course based on the EULAR Textbook on Rheumatic

Diseases) is #EULARonlinecourseOnRheumaticDiseases. Further, the hashtag #EMEUNETonCourse

is used in all Tweets. Other hashtags can be used to specify the chapter or topic of the Tweet.

Because courses contain copyright content, it is stressed that all posts should comply with normal

copyright regulations, e.g. do not post anything without proper citations and do not copy paste content

from the courses.

JUNE 19

OUTCOME MEASURES LIBRARY

29

OUTCOME MEASURES LIBRARY (OML)

The EULAR Outcome Measures Library (OML) aims to be a comprehensive database of validated

instruments (indices, questionnaires, scales, or others), with an emphasis on patient-reported

outcomes (PRO) used in rheumatology. The OML includes detailed descriptions of each

instrument, such as the settings in which it has been validated, recommendations for use and

different language versions of each instrument. Also, guidelines for interpretation of results in both

practice and research settings are provided. Instruments are categorized by disease or by topic.

The EULAR OML was created by rheumatologists, health professionals, students and patients, all

of whom are engaged in this field of research. It is an ongoing project, and many people have

already contributed. The OML initiative is open to volunteers who can help keep track of new

PROs in our field.

For more information visit:

http://oml.eular.org/

JUNE 19

http://oml.eular.org/

Young investigators of EMEUNET are an integral part of all task forces and

committees working on new EULAR recommendations. This is a wonderful

chance for EMEUNET to increase its visibility and for you to accelerate your

academic career.

EMEUNET members with interest in methodology and previous experience in

EULAR Task Forces can also have the opportunity to become junior

methodologists. For further information, please contact

[email protected]

Take a look at emails from EMEUNET and find the opportunity most

suitable for you!

JOIN EULAR TASK FORCES AND COMMITTEES

SHARE YOUR IDEAS!

Over the years EMEUNET has developed several projects covering different topics

and areas of interest. However, we appreciate any suggestions and welcome new

ideas to expand on what we currently offer to EMEUNET members. Make your

voice heard and share your ideas with us!

It is easy, just write down some lines to summarize your proposal and send it either

via email at [email protected] or through our website

(http://emeunet.eular.org/contact_us.cfm). Don’t forget to provide your contacts so

we can come back to you for additional details!

More information about EMEUNET can be found at http://emeunet.eular.org

www.facebook.com/EMEUNET

www.twitter.com/EMEUNET

http://www.linkedin.com

30JUNE 19

mailto:[email protected]

mailto:[email protected]

http://emeunet.eular.org/contact_us.cfm

http://emeunet.eular.org/

http://www.linkedin.com/

EDITION JUNE 2019 ISSN 2521-7852 EULAR DO …...EDITION JUNE 2019 EULAR DO NOT MISS ISSN 2521-7852...

Documents

Transcript of EDITION JUNE 2019 ISSN 2521-7852 EULAR DO …...EDITION JUNE 2019 EULAR DO NOT MISS ISSN 2521-7852...